Replies to post #200409 on Biotech Values

[exwannabe]

PLTA: That was a close miss

The primary cohort was p=.057

The alpha assigned secondaries would have been highly stat sig had the primary not failed.

This is perhaps a case where the company and investors should be hoping that the FDA is infested by Dew's cockroaches :-)

[biocqr]

Speaking of red flags...in today's AF column...

Biotech Stock Mailbag: How to Spot Red Flags in Clinical Trial Data

http://www.thestreet.com/story/13506801/1/biotech-stock-mailbag-how-to-spot-red-flags-in-clinical-trial-data.html

[DewDiligence]

PTLA data-mines (failed) APEX study of Betrixaban:

http://finance.yahoo.com/news/portola-pharmaceuticals-announces-three-phase-211500583.html

This will be a pretty good test of how loose the FDA really is.